Joshua Aiello - Apr 4, 2025 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Role: Principal Accounting Officer
Signature: /s/ Andrew Taylor, Attorney-in-Fact
Stock symbol: OBIO
Transactions as of: Apr 4, 2025
Transactions value $: $0
Form type: 4
Date filed: 4/4/2025, 09:40 PM
Previous filing: Mar 28, 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OBIO	Stock Option (Right to Buy)	Award	$0	+48K		$0.00	48K	Apr 4, 2025	Common Stock	48K	$2.76	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock options will vest as follows: (i) 12,000 of the stock options will vest on April 4, 2026 (the "Vesting Commencement Date") and (ii) the remaining 36,000 stock options will vest in equal installments every three months on the same day of the month as the Vesting Commencement Date, starting on July 4, 2026, subject to the Reporting Person's continuous service through such dates.